Royston Ivor (CIK 0001026765)

Latest company ownership

Shares held
625,545
Last filed at
Mar 22, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q1 2025Q4
Shares held
18,599
Last filed at
Sep 12, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 25, 2022 Aug 29, 2022 Viracta Therapeutics, Inc. CEO Sell 42.5 -13,379 -2.08% ✗ $53.7K
May 25, 2022 May 27, 2022 Viracta Therapeutics, Inc. CEO Sell 46.3 -13,162 -2.08% ✗ $25K
Feb 25, 2022 Mar 1, 2022 Viracta Therapeutics, Inc. CEO Sell 46.3 -14,635 -2.35% ✗ $40.7K
Nov 25, 2021 Nov 29, 2021 Viracta Therapeutics, Inc. CEO Sell 42.5 -27,747 -4.49% ✗ $133.5K
Nov 15, 2021 Nov 15, 2021 Viracta Therapeutics, Inc. CEO Buy 78.8 +8,000 1.43% ✗ $44.5K
Mar 20, 2017 Mar 22, 2017 Syndax Pharmaceuticals Inc Director Sell 17.5 -125,000 -16.65% ✗ $1.7M
Mar 8, 2016 Mar 8, 2016 Syndax Pharmaceuticals Inc Director Buy 100.0 +150,000 24.98% ✗ $1.8M